ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry P05787


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name K2C8_HUMAN
Primary accession number P05787
Secondary accession numbers Q14099 Q14716 Q14717 Q53GJ0 Q6DHW5 Q6GMY0 Q6P4C7 Q96J60
Integrated into Swiss-Prot on November 1, 1988
Sequence was last modified on January 23, 2007 (Sequence version 7)
Annotations were last modified on    November 4, 2008 (Entry version 111)
Name and origin of the protein
Protein name Keratin, type II cytoskeletal 8
Synonyms Cytokeratin-8
CK-8
Keratin-8
K8
Gene name
Name: KRT8
Synonyms: CYK8
From
Homo sapiens (Human) [TaxID: 9606] 
Taxonomy Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo.
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
DOI=10.1016/0378-1119(90)90285-Y; PubMed=1691124 [NCBI, ExPASy, EBI, Israel, Japan]
Krauss S., Franke W.W.;
"Organization and sequence of the human gene encoding cytokeratin 8.";
Gene 86:241-249(1990).
[2]
NUCLEOTIDE SEQUENCE [MRNA].
PubMed=1692965 [NCBI, ExPASy, EBI, Israel, Japan]
Yamamoto R., Kao L.C., McKnight C.E., Strauss J.F. III;
"Cloning and sequence of cDNA for human placental cytokeratin 8. Regulation of the mRNA in trophoblastic cells by cAMP.";
Mol. Endocrinol. 4:370-374(1990).
[3]
NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
TISSUE=Placenta;
PubMed=1705144 [NCBI, ExPASy, EBI, Israel, Japan]
Waseem A., Alexander C.M., Steel J.B., Lane E.B.;
"Embryonic simple epithelial keratins 8 and 18: chromosomal location emphasizes difference from other keratin pairs.";
New Biol. 2:464-478(1990).
[4]
NUCLEOTIDE SEQUENCE [MRNA], AND PHOSPHORYLATION AT SER-24 AND SER-432.
DOI=10.1074/jbc.272.11.7556; PubMed=9054461 [NCBI, ExPASy, EBI, Israel, Japan]
Ku N.-O., Omary M.B.;
"Phosphorylation of human keratin 8 in vivo at conserved head domain serine 23 and at epidermal growth factor-stimulated tail domain serine 431.";
J. Biol. Chem. 272:7556-7564(1997).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Kidney;
Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT CYS-62.
TISSUE=Colon, Liver, Lung, and Placenta;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[7]
NUCLEOTIDE SEQUENCE [MRNA] OF 1-231.
PubMed=2471065 [NCBI, ExPASy, EBI, Israel, Japan]
Kulesh D.A., Cecena G., Darmon Y.M., Vasseur M., Oshima R.G.;
"Posttranslational regulation of keratins: degradation of mouse and human keratins 18 and 8.";
Mol. Cell. Biol. 9:1553-1565(1989).
[8]
NUCLEOTIDE SEQUENCE [MRNA] OF 205-483.
PubMed=2434381 [NCBI, ExPASy, EBI, Israel, Japan]
Leube R.E., Bosch F.X., Romano V., Zimbelmann R., Hofler H., Franke W.W.;
"Cytokeratin expression in simple epithelia. III. Detection of mRNAs encoding human cytokeratins nos. 8 and 18 in normal and tumor cells by hybridization with cDNA sequences in vitro and in situ.";
Differentiation 33:69-85(1986).
[9]
PARTIAL PROTEIN SEQUENCE.
TISSUE=Colon carcinoma;
DOI=10.1002/elps.1150180344; PubMed=9150948 [NCBI, ExPASy, EBI, Israel, Japan]
Ji H., Reid G.E., Moritz R.L., Eddes J.S., Burgess A.W., Simpson R.J.;
"A two-dimensional gel database of human colon carcinoma proteins.";
Electrophoresis 18:605-613(1997).
[10]
GLYCOSYLATION.
PubMed=1371281 [NCBI, ExPASy, EBI, Israel, Japan]
Chou C.F., Smith A.J., Omary M.B.;
"Characterization and dynamics of O-linked glycosylation of human cytokeratin 8 and 18.";
J. Biol. Chem. 267:3901-3906(1992).
[11]
INTERACTION WITH KRT20, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
DOI=10.1016/S0003-9969(00)00050-9; PubMed=10973561 [NCBI, ExPASy, EBI, Israel, Japan]
Barrett A.W., Cort E.M., Patel P., Berkovitz B.K.B.;
"An immunohistological study of cytokeratin 20 in human and mammalian oral epithelium.";
Arch. Oral Biol. 45:879-887(2000).
[12]
INTERACTION WITH PNN.
DOI=10.1074/jbc.275.20.14910; PubMed=10809736 [NCBI, ExPASy, EBI, Israel, Japan]
Shi J., Sugrue S.P.;
"Dissection of protein linkage between keratins and pinin, a protein with dual location at desmosome-intermediate filament complex and in the nucleus.";
J. Biol. Chem. 275:14910-14915(2000).
[13]
PHOSPHORYLATION AT SER-74.
DOI=10.1074/jbc.M111436200; PubMed=11781324 [NCBI, ExPASy, EBI, Israel, Japan]
He T., Stepulak A., Holmstrom T.H., Omary M.B., Eriksson J.E.;
"The intermediate filament protein keratin 8 is a novel cytoplasmic substrate for c-Jun N-terminal kinase.";
J. Biol. Chem. 277:10767-10774(2002).
[14]
PHOSPHORYLATION AT SER-74, AND MUTAGENESIS OF LEU-72 AND SER-74.
DOI=10.1074/jbc.M107623200; PubMed=11788583 [NCBI, ExPASy, EBI, Israel, Japan]
Ku N.O., Azhar S., Omary M.B.;
"Keratin 8 phosphorylation by p38 kinase regulates cellular keratin filament reorganization: modulation by a keratin 1-like disease causing mutation.";
J. Biol. Chem. 277:10775-10782(2002).
[15]
INTERACTION WITH TCHP.
DOI=10.1242/jcs.01667; PubMed=15731013 [NCBI, ExPASy, EBI, Israel, Japan]
Nishizawa M., Izawa I., Inoko A., Hayashi Y., Nagata K., Yokoyama T., Usukura J., Inagaki M.;
"Identification of trichoplein, a novel keratin filament-binding protein.";
J. Cell Sci. 118:1081-1090(2005).
[16]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21; SER-22; SER-24; SER-37 AND SER-43, AND MASS SPECTROMETRY.
DOI=10.1021/pr050048h; PubMed=16083285 [NCBI, ExPASy, EBI, Israel, Japan]
Kim J.-E., Tannenbaum S.R., White F.M.;
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells.";
J. Proteome Res. 4:1339-1346(2005).
[17]
FUNCTION, SUBUNIT, AND TISSUE SPECIFICITY.
DOI=10.1091/mbc.E05-02-0112; PubMed=16000376 [NCBI, ExPASy, EBI, Israel, Japan]
Stone M.R., O'Neill A., Catino D., Bloch R.J.;
"Specific interaction of the actin-binding domain of dystrophin with intermediate filaments containing keratin 19.";
Mol. Biol. Cell 16:4280-4293(2005).
[18]
INTERACTION WITH HCV CORE PROTEIN.
DOI=10.1002/pmic.200401093; PubMed=15846844 [NCBI, ExPASy, EBI, Israel, Japan]
Kang S.-M., Shin M.-J., Kim J.-H., Oh J.-W.;
"Proteomic profiling of cellular proteins interacting with the hepatitis C virus core protein.";
Proteomics 5:2227-2237(2005).
[19]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-253 AND SER-330, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1016/j.cell.2006.09.026; PubMed=17081983 [NCBI, ExPASy, EBI, Israel, Japan]
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.";
Cell 127:635-648(2006).
[20]
INTERACTION WITH KRT20.
DOI=10.1074/jbc.M512284200; PubMed=16608857 [NCBI, ExPASy, EBI, Israel, Japan]
Zhou Q., Cadrin M., Herrmann H., Chen C.-H., Chalkley R.J., Burlingame A.L., Omary M.B.;
"Keratin 20 serine 13 phosphorylation is a stress and intestinal goblet cell marker.";
J. Biol. Chem. 281:16453-16461(2006).
[21]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1038/nbt1240; PubMed=16964243 [NCBI, ExPASy, EBI, Israel, Japan]
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
"A probability-based approach for high-throughput protein phosphorylation analysis and site localization.";
Nat. Biotechnol. 24:1285-1292(2006).
[22]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-451, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1073/pnas.0507066103; PubMed=16565220 [NCBI, ExPASy, EBI, Israel, Japan]
Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
"Phosphoproteome analysis of the human mitotic spindle.";
Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
[23]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-204 AND TYR-267, AND MASS SPECTROMETRY.
DOI=10.1016/j.cell.2007.11.025; PubMed=18083107 [NCBI, ExPASy, EBI, Israel, Japan]
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L., Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J., Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X., Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
"Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.";
Cell 131:1190-1203(2007).
[24]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-24 AND THR-26, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1021/pr070152u; PubMed=17924679 [NCBI, ExPASy, EBI, Israel, Japan]
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
"Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
J. Proteome Res. 6:4150-4162(2007).
[25]
VARIANTS CRYPTOGENIC CIRRHOSIS VAL-53; CYS-54 AND CYS-62, AND VARIANT VAL-63.
DOI=10.1073/pnas.0936165100; PubMed=12724528 [NCBI, ExPASy, EBI, Israel, Japan]
Ku N.-O., Darling J.M., Krams S.M., Esquivel C.O., Keeffe E.B., Sibley R.K., Lee Y.M., Wright T.L., Omary M.B.;
"Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies.";
Proc. Natl. Acad. Sci. U.S.A. 100:6063-6068(2003).
Comments
  • FUNCTION: Together with KRT19, helps to link the contractile apparatus to dystrophin at the costameres of striated muscle.
  • SUBUNIT: Heterotetramer of two type I and two type II keratins. keratin-8 associates with keratin-18. Associates with KRT20. Interacts with HCV core protein and PNN. When associated with KRT19, interacts with DMD. Interacts with TCHP.
  • INTERACTION:
    O75503:CLN5; NbExp=1; IntAct=EBI-297852, EBI-1043514;
    O95757:HSPA4L; NbExp=1; IntAct=EBI-297852, EBI-358652;
    P05783:KRT18; NbExp=2; IntAct=EBI-297852, EBI-297888;
    Q00987:MDM2; NbExp=1; IntAct=EBI-297852, EBI-389668;
  • SUBCELLULAR LOCATION: Cytoplasm.
  • TISSUE SPECIFICITY: Observed in muscle fibers accumulating in the costameres of myoplasm at the sarcolemma membrane in structures that contain dystrophin and spectrin. Expressed in gingival mucosa and hard palate of the oral cavity.
  • PTM: Phosphorylation on serine residues is enhanced during EGF stimulation and mitosis. Ser-74 phosphorylation plays an important role in keratin filament reorganization.
  • PTM: O-glycosylated at multiple sites; glycans consist of single N-acetylglucosamine residues.
  • DISEASE: Defects in KRT8 are a cause of cryptogenic cirrhosis [MIM:215600].
  • MISCELLANEOUS: There are two types of cytoskeletal and microfibrillar keratin: I (acidic; 40-55 kDa) and II (neutral to basic; 56-70 kDa).
  • SIMILARITY: Belongs to the intermediate filament family.
  • WEB RESOURCE: Name=Human Intermediate Filament Mutation Database; URL="http://www.interfil.org";.
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
M34482; AAA35763.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M34225; AAA35748.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
X74929; CAA52882.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
X74981; CAA52916.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U76549; AAB18966.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AK222941; BAD96661.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC000654; AAH00654.3; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC063513; AAH63513.2; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC073760; AAH73760.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC075839; AAH75839.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M26512; AAA51542.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
X12882; CAA31376.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
X98614; CAA67203.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
PIR A34720; A34720.
RefSeq NP_002264.1; -.
UniGene Hs.533782
3D structure databases
HSSP P08670; 1GK7. [HSSP ENTRY / PDB]
ModBase P05787.
Protein-protein interaction databases
DIP DIP:424N; -.
IntAct P05787; -.
PTM databases
GlycoSuiteDB P05787; -.
PhosphoSite P05787; -.
2D gel databases
SWISS-2DPAGE P05787; -.
Siena-2DPAGE P05787; -.
Organism-specific databases
H-InvDB HIX0010658; -.
HIX0035240; -.
HGNC HGNC:6446; KRT8.
GenAtlas KRT8.
HPA CAB000131; -.
CAB001696; -.
MIM 148060; gene. [NCBI / EBI]
215600; phenotype. [NCBI / EBI]
PharmGKB PA30234; -.
GeneCards P05787.
Gene expression databases
ArrayExpress P05787; -.
GermOnline ENSG00000170421; Homo sapiens.
Ontologies
GO
GO:0005882; Cellular component: intermediate filament (non-traceable author statement from UniProtKB).
GO:0005515; Molecular function: protein binding (inferred from physical interaction from UniProtKB).
GO:0005198; Molecular function: structural molecule activity (non-traceable author statement from UniProtKB).
GO:0007010; Biological process: cytoskeleton organization (non-traceable author statement from UniProtKB).
QuickGo view.
Family and domain databases
InterPro IPR016044; F.
IPR001664; IF.
IPR002957; Keratin_I.
IPR003054; Keratin_II.
Graphical view of domain structure.
PANTHER PTHR23239; IF; 1.
PTHR23239:SF18; Keratin_II; 1.
Pfam PF00038; Filament; 1.
Pfam graphical view of domain structure.
PRINTS PR01248; TYPE1KERATIN.
PR01276; TYPE2KERATIN.
PROSITE PS00226; IF; 1.
BLOCKS P05787.
ProtoNet P05787.
Proteomic databases
PeptideAtlas P05787; -.
Genome annotation databases
Ensembl ENSG00000170421; Homo sapiens. [Contig view]
GeneID 3856; -.
KEGG hsa:3856; -.
Phylogenomic databases
HOVERGEN P05787; -.
Other
DrugBank DB00009; Alteplase.
DB00029; Anistreplase.
DB00015; Reteplase.
DB00031; Tenecteplase.
LinkHub P05787; -.
NextBio 15173; -.
SOURCE KRT8; Homo sapiens.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
Coiled coil; Cytoplasm; Direct protein sequencing; Disease mutation; Glycoprotein; Host-virus interaction; Intermediate filament; Keratin; Phosphoprotein; Polymorphism.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom   To Length Description FTId
INIT_MET   1     1        Removed. 
CHAIN   2   483  482     Keratin, type II cytoskeletal 8. PRO_0000063740
REGION   2    90  89     Head. 
REGION   91   398  308     Rod. 
REGION   91   126  36     Coil 1A. 
REGION   127   143  17     Linker 1. 
REGION   144   235  92     Coil 1B. 
REGION   236   259  24     Linker 12. 
REGION   260   398  139     Coil 2. 
REGION   261   382  122     Necessary for interaction with PNN. 
REGION   399   483  85     Tail. 
COMPBIAS   9    49  41     Ser-rich. 
SITE   342   342  1     Stutter. 
MOD_RES   9     9        Phosphoserine (By similarity). 
MOD_RES   13    13        Phosphoserine (By similarity). 
MOD_RES   21    21        Phosphoserine. 
MOD_RES   22    22        Phosphoserine. 
MOD_RES   24    24        Phosphoserine. 
MOD_RES   26    26        Phosphothreonine. 
MOD_RES   27    27        Phosphoserine. 
MOD_RES   34    34        Phosphoserine (By similarity). 
MOD_RES   37    37        Phosphoserine. 
MOD_RES   43    43        Phosphoserine. 
MOD_RES   44    44        Phosphoserine (By similarity). 
MOD_RES   74    74        Phosphoserine; by MAPK. 
MOD_RES   204   204        Phosphotyrosine. 
MOD_RES   253   253        Phosphoserine. 
MOD_RES   267   267        Phosphotyrosine. 
MOD_RES   330   330        Phosphoserine. 
MOD_RES   417   417        Phosphoserine (By similarity). 
MOD_RES   424   424        Phosphoserine (By similarity). 
MOD_RES   432   432        Phosphoserine; by CaMK2 and MAPK. 
MOD_RES   451   451        Phosphoserine. 
MOD_RES   475   475        Phosphoserine (By similarity). 
MOD_RES   478   478        Phosphoserine (By similarity). 
VARIANT   53    53  1     G -> V (in cryptogenic cirrhosis). VAR_023058 
VARIANT   54    54  1     Y -> C (in cryptogenic cirrhosis). VAR_023059 
VARIANT   62    62  1     G -> C (in cryptogenic cirrhosis). VAR_023060 
VARIANT   63    63  1     I -> V. VAR_023061 
MUTAGEN   72    72        L->P: Increases phosphorylation. 
MUTAGEN   74    74        S->A: Generates normal-appearing filaments, that remain stable after okadaic acid treatment. 
MUTAGEN   74    74        S->D: Generates normal-appearing filaments, that are destabilized by okadaic acid. 
CONFLICT   77    77        V -> S (in Ref. 2; AAA35748). 
CONFLICT   201   201        D -> DVD (in Ref. 3; CAA52882). 
CONFLICT   232   232        I -> L (in Ref. 8; CAA67203). 
CONFLICT   257   257        D -> E (in Ref. 2; AAA35748). 
CONFLICT   324   324        L -> F (in Ref. 5; BAD96661). 
CONFLICT   384   384        L -> M (in Ref. 8; CAA67203). 
CONFLICT   387   387        E -> D (in Ref. 2; AAA35748). 
CONFLICT   401   401        R -> P (in Ref. 2; AAA35748). 
CONFLICT   417   417        S -> G (in Ref. 1; AAA35763, 2; AAA35748, 8; CAA67203 and 9). 
CONFLICT   429   429        G -> D (in Ref. 2; AAA35748 and 8). 
CONFLICT   430   433        LTSP -> SQA (in Ref. 1; AAA35763). 
CONFLICT   431   431        T -> A (in Ref. 8; CAA67203). 
CONFLICT   432   432        S -> D (in Ref. 2; AAA35748 and 8; CAA67203). 
Sequence information
Length: 483 AA [This is the length of the unprocessed precursor] Molecular weight: 53704 Da [This is the MW of the unprocessed precursor] CRC64: B0BC730B65929D37 [This is a checksum on the sequence]
        10         20         30         40         50         60 
MSIRVTQKSY KVSTSGPRAF SSRSYTSGPG SRISSSSFSR VGSSNFRGGL GGGYGGASGM 

        70         80         90        100        110        120 
GGITAVTVNQ SLLSPLVLEV DPNIQAVRTQ EKEQIKTLNN KFASFIDKVR FLEQQNKMLE 

       130        140        150        160        170        180 
TKWSLLQQQK TARSNMDNMF ESYINNLRRQ LETLGQEKLK LEAELGNMQG LVEDFKNKYE 

       190        200        210        220        230        240 
DEINKRTEME NEFVLIKKDV DEAYMNKVEL ESRLEGLTDE INFLRQLYEE EIRELQSQIS 

       250        260        270        280        290        300 
DTSVVLSMDN SRSLDMDSII AEVKAQYEDI ANRSRAEAES MYQIKYEELQ SLAGKHGDDL 

       310        320        330        340        350        360 
RRTKTEISEM NRNISRLQAE IEGLKGQRAS LEAAIADAEQ RGELAIKDAN AKLSELEAAL 

       370        380        390        400        410        420 
QRAKQDMARQ LREYQELMNV KLALDIEIAT YRKLLEGEES RLESGMQNMS IHTKTTSGYA 

       430        440        450        460        470        480 
GGLSSAYGGL TSPGLSYSLG SSFGSGAGSS SFSRTSSSRA VVVKKIETRD GKLVSESSDV 


LPK 

P05787 in FASTA format

View entry in original UniProtKB/Swiss-Prot format
View entry in raw text format (no links)
Report form for errors/updates in this UniProtKB/Swiss-Prot entry

BLAST logo BLAST submission on ExPASy/SIB
or at NCBI (USA)
Tools Sequence analysis tools: ProtParam, ProtScale, Compute pI/Mw, PeptideMass, PeptideCutter, Dotlet (Java)
PROSITE logo ScanProsite, MotifScan SWISS-MODEL Submit a homology modeling request to SWISS-MODEL
NPSA logo NPSA Sequence analysis tools

ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
 Hosted by ch flag SIB Switzerland Mirror sites: Australia  Brazil  Canada  China  Korea
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!